Dominik Leisi

Dominik Leisi is an experienced technology transfer and business development professional specializing in the life science and biomedical sectors with extensive project management experience in medical device and pharmaceutical product development.

Currently serving as a Senior Business Manager at UCL Business Ltd, Dominik leads the identification, evaluation, protection, and commercial development of intellectual property originating from the UCL Cancer Institute and Institute of Child Health.

He manages a diverse portfolio of technologies including small molecules, biologicals, and gene therapies for treating various diseases, with a track record of securing substantial translational funding from sources like WellcomeTrust, MRC DPFS, and Innovate UK.

Dominik has also been involved in negotiating and executing licensing deals, clinical trial collaborations, research collaborations, and the establishment of UCLB spin-outs.

Before his tenure at UCLB, Dominik worked at BTG as a Technical Lead overseeing projects at the R&D and commercial interface related to drug-eluting microspheres, and earlier in his career, he designed and developed dental implants and instruments at Nobel Biocare.

In terms of education, Dominik holds a Master of Science (MSc) in Innovation, Entrepreneurship, and Management with Distinction from Imperial College London, and a Bachelor of Sciences in Life Science Technologies with a focus on Medical Technology from Fachhochschule Nordwestschweiz FHNW.

He also has a background in Accounting, a Vocational Baccalaureate, and completed apprenticeships in Polymechanics.

Throughout his career, Dominik has held roles such as Business Manager Biopharm, Project Development Manager, and Investment Manager with UCL Technology Fund at AlbionVC.

His professional journey encompasses diverse experiences in technology transfer, project management, IP commercialization, and business development within the medical technology and pharmaceutical sectors.